Systemic Inflammation Is Associated with Worse Outcomes from SARS-CoV-2 Infection but Not Neutralizing Antibody

Scientists determined the association between neutralizing antibody responses, inflammation, and clinical outcomes in hospitalized patients with COVID-19.